A cost-effectiveness evaluation comparing originator follitropin alfa to the biosimilar for the treatment of infertility

OBJECTIVES: To perform a cost-effectiveness evaluation comparing the originator follitropin alfa (Gonal-f(®)) to the biosimilar (Bemfola(®)) in the Italian and Spanish contexts, with an assessment of the German and UK backgrounds. METHODS: Starting from the study by Rettenbacher et al, a cost-effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Gizzo, Salvatore, Garcia-Velasco, Juan A, Heiman, Franca, Ripellino, Claudio, Bühler, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153281/
https://www.ncbi.nlm.nih.gov/pubmed/27994486
http://dx.doi.org/10.2147/IJWH.S118687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153281/
https://www.ncbi.nlm.nih.gov/pubmed/27994486
http://dx.doi.org/10.2147/IJWH.S118687

Ejemplares similares